FORT LAUDERDALE, Fla. — At the Retina World Congress, Darius M. Moshfeghi, MD, professor and chairman of the retina service at Byers Eye Institute at Stanford University, discusses the advantages of anti-VEGF agents over laser for the treatment of retinopathy of prematurity, but he cautions that it is not a “one-and-done” therapy.

Full Story →

FORT LAUDERDALE, Fla. — At the Retina World Congress, Darius M. Moshfeghi, MD, professor and chairman of the retina service at Byers Eye Institute at Stanford University, discusses the advantages of anti-VEGF agents over laser for the treatment of retinopathy of prematurity, but he cautions that it is not a “one-and-done” therapy.

Full Story →